Emma C. E. Wassenaar

University Medical Center Utrecht — Netherlands

Medicine · Health Sciences

17h-index1.2kcitations37works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Intraperitoneal and Appendiceal Malignancies(27), Appendicitis Diagnosis and Management(16), Hepatocellular Carcinoma Treatment and Prognosis(11), Ovarian cancer diagnosis and treatment(7), Cancer Genomics and Diagnostics(5)

Publications37 total

The Clinical Presentation of Anastomotic Leakage Compared Between CRS-HIPEC and Conventional Colorectal Surgery
Annals of Surgical Oncology·2025
Treatment of colorectal peritoneal metastases with oxaliplatin induces biomarkers predicting response to immune checkpoint blockade
Translational Oncology·2025· 1 citedOpen Access
Abstract 3889: Access and selection shapes peritoneal metastasis evolution in colorectal cancer
Cancer Research·2025
Quantifying cell divisions along evolutionary lineages in cancer
Nature Genetics·2025· 6 citedOpen Access
A unique interplay of access and selection shapes peritoneal metastasis evolution in colorectal cancer
2024· 3 citedOpen Access
Reclassification of Appendiceal Mucinous Neoplasms and Associated Pseudomyxoma Peritonei According to the Peritoneal Surface Oncology Group International Consensus: Clinicopathological Reflections of a Two-Center Cohort Study
Annals of Surgical Oncology·2024· 4 cited
Patient-reported outcomes during first-line palliative systemic therapy alternated with pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: a single-arm phase II trial (CRC-PIPAC-II)
Surgical Endoscopy·2024· 5 citedOpen Access
First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II)
European Journal of Surgical Oncology·2024· 5 cited
Comparing patient reported abdominal pain between patients treated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy (PIPAC-OX) and primary colorectal cancer surgery
Scientific Reports·2023· 3 citedOpen Access
Adjuvant Hyperthermic Intraperitoneal Chemotherapy in Patients With Locally Advanced Colon Cancer (COLOPEC): 5-Year Results of a Randomized Multicenter Trial
Journal of Clinical Oncology·2023· 36 citedOpen Access
727 OUTCOMES OF FIRST-LINE PALLIATIVE SYSTEMIC THERAPY ALTERNATED WITH OXALIPLATIN-BASED PRESSURIZED INTRAPERITONEAL AEROSOL CHEMOTHERAPY IN PATIENTS WITH UNRESECTABLE COLORECTAL PERITONEAL METASTASES IN A MULTICENTER, SINGLE-ARM, PHASE II TRIAL
Gastroenterology·2023
Lymphatic Invasion of Plakoglobin-Dependent Tumor Cell Clusters Drives Formation of Polyclonal Lung Metastases in Colon Cancer
Gastroenterology·2023· 17 citedOpen Access
Palliative systemic therapy and oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy in patients with unresectable colorectal peritoneal metastases in a phase II trial (CRC-PIPAC-II)
European Journal of Surgical Oncology·2023
The measured distance between tumor cells and the peritoneal surface predicts the risk of peritoneal metastases and offers an objective means to differentiate between pT3 and pT4a colon cancer
Modern Pathology·2022· 7 citedOpen Access
Fibroblast activation protein identifies Consensus Molecular Subtype 4 in colorectal cancer and allows its detection by 68Ga-FAPI-PET imaging
British Journal of Cancer·2022· 29 citedOpen Access
Peritoneal metastases from colorectal cancer belong to Consensus Molecular Subtype 4 and are sensitised to oxaliplatin by inhibiting reducing capacity
British Journal of Cancer·2022· 61 citedOpen Access
Patient-reported outcomes during repetitive pressurized intraperitoneal aerosol chemotherapy (oxaliplatin) for unresectable colorectal peritoneal metastases: a multicenter, single-arm, phase 2 trial
European Journal of Surgical Oncology·2022
Patient-reported outcomes during repetitive oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for isolated unresectable colorectal peritoneal metastases in a multicenter, single-arm, phase 2 trial (CRC-PIPAC)
Surgical Endoscopy·2021· 10 citedOpen Access
Perioperative Systemic Therapy vs Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Alone for Resectable Colorectal Peritoneal Metastases
JAMA Surgery·2021· 66 citedOpen Access
First-line palliative systemic therapy alternated with electrostatic pressurised intraperitoneal aerosol chemotherapy (oxaliplatin) for isolated unresectable colorectal peritoneal metastases: protocol of a multicentre, single-arm, phase II study (CRC-PIPAC-II)
BMJ Open·2021· 13 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Djamila Boerma(26), Koen P. Rovers(21), Ignace H. J. T. de Hingh(20), Onno Kranenburg(19), Simon W. Nienhuijs(18), Maartje Los(17), Robin J. Lurvink(16), Marinus J. Wiezer(13), Jacobus W. A. Burger(12), Geert-Jan Creemers(10), Paulien Rauwerdink(10), Remond J.A. Fijneman(9), Alexander Constantinides(9), Clément J.R. Huysentruyt(9), Pétur Snæbjörnsson(8), Joost Nederend(8), Maarten J. Deenen(8), Arend G. J. Aalbers(7), Niels F. M. Kok(7), Arjen J. Witkamp(7)